Nationwide Study Shows BNT162b2 mRNA Vaccine Is Effective; In mass vaccination setting, vaccine is effective for symptomatic COVID-19, hospitalization, severe disease, death.

Press/Media

Period24 Feb 2021

Media coverage

1

Media coverage

  • TitleNationwide Study Shows BNT162b2 mRNA Vaccine Is Effective; In mass vaccination setting, vaccine is effective for symptomatic COVID-19, hospitalization, severe disease, death.
    Media name/outletPhysician's Briefings
    Country/TerritoryUnited States
    Date24/02/21
    PersonsNoa Dagan